-
公开(公告)号:EP1699767A2
公开(公告)日:2006-09-13
申请号:EP04816043.6
申请日:2004-12-31
申请人: Scios, Inc.
IPC分类号: C07D239/90 , C07D239/91 , C07D471/04
CPC分类号: C07D239/91 , C07D471/04
摘要: The present invention is directed to a rpocess for making 2-substituted pyridopyrimidones. In particular, 2-substituted pyridopyrimidones are made through the single step reaction of suitable acid derivatives with desired derivatives of amidines.
摘要翻译: 本发明涉及制备2-取代的吡啶并嘧啶酮的方法。 具体地说,2-取代的吡啶并嘧啶酮是通过合适的酸衍生物与期望的脒衍生物的单步反应制备的。
-
公开(公告)号:EP1675830A2
公开(公告)日:2006-07-05
申请号:EP04789449.8
申请日:2004-09-30
申请人: SCIOS INC.
发明人: DUGAR, Sundeep , MCENROE, Glen , CHAKRAVARTY, Sarvajit , MURPHY, Alison , PERUMATTAM, John, Joseph , CONTE, Aurelia
IPC分类号: C07D213/75
CPC分类号: C07D405/12 , C07D213/75 , C07D239/48 , C07D401/12 , C07D405/14 , C07D409/12 , C07D417/12
摘要: The invention is directed to compounds and methods to inhibit p38 kinase wherein the compounds are a pyrimidine or pyridine coupled to two mandatory substituents.
-
公开(公告)号:EP1608631A2
公开(公告)日:2005-12-28
申请号:EP04758392.7
申请日:2004-03-26
申请人: SCIOS INC.
IPC分类号: C07D239/70 , C07D487/04 , C07D491/048 , C07D495/04
CPC分类号: C07D487/04 , A61K31/517 , C07D239/94 , C07D401/04 , C07D401/12 , C07D401/14 , C07D413/14 , C07D471/04 , C07D491/04 , C07D493/04 , C07D495/04 , C07D498/04
摘要: Compounds in which a pyrimidine nucleus is bridged at the (5) and (6) position and are further substituted at positions (2) and (4) with substituents comprising aromatic moieties are useful in treating subjects with conditions ameliorated by inhibition of TGFβ activity.
摘要翻译: 其中嘧啶核在(5)和(6)位桥接并且在位置(2)和(4)处用包含芳族部分的取代基进一步取代的化合物可用于治疗患有通过抑制TGFβ活性而改善的病症的受试者。
-
-